At Restore, we believe that an active lifestyle is a key ingredient to a fuller, happier life—and that starts with sustaining a healthy weight. Additionally, obesity is associated with many life-threatening diseases, including, but not limited to diabetes, cancer, hormonal issues, stroke, and cardiovascular disease. We were determined to develop a weight-loss program that was not only clinically effective and backed by science, but also deeply personalized and achievable. The wellness industry is filled with diet and lifestyle fads that claim to deliver weight-loss results, but we were committed to developing a weight management program that was both aspirational and achievable—combining clinically effective components with personalized plans that would deliver results.

Qualification for the Weight Management program for those 18 years of age or older is determined by a clinician. Each individual’s body composition, skeletal muscle mass, metabolic health biomarkers/labs, and medical history is analyzed for qualification. Not all candidates will qualify for medication.

At Restore, we’re committed to supporting you on your weight loss journey, whether you qualify for these medications or not. We will work with you to create a personalized plan featuring Restore therapies that support weight loss, including Infrared Sauna, Whole Body Cryotherapy, Lipo + B12 and Vitamin D shots and IV Therapy with L-Carnitine, Trace Minerals, and B vitamins.

To assess your metabolic health, we evaluate essential blood-based biomarkers regularly as part of our Metabolic Panel.

These evaluations include:

Comprehensive Metabolic Panel (CMP): Monitors components of kidney health, hydration, liver function, nutritional status, blood sugar and high blood pressure effects.

HbA1C: Tracks average blood sugar levels over three months,

Lipid Panel: Measures different forms of cholesterol in your blood, including total cholesterol, HDL cholesterol (the "good" cholesterol), LDL cholesterol (the "bad" cholesterol) and triglycerides.

Thyroid Stimulating Hormone (TSH): Evaluates thyroid function and its impact on metabolism and weight.

hs-CRP: A marker of total body inflammation.

Not at this time. We are working diligently behind the scenes to make external lab work that clients have already completed submissible to qualify for the Weight Management Program.

BMI is a commonly used measurement that takes into account a person’s height and weight. However, it does not distinguish between excess fat, muscle or bone mass; nor does it provide any indication of the distribution of fat among individuals. On the other hand, body composition provides a more comprehensive understanding of an individual’s body makeup by assessing the percentage of fat, muscle and other tissues. There are also significant differences in body types and cardiometabolic health risks based on biological sex, age, race and ethnicity (Learn more about the InBody Scan here.) BMI, when used in isolation, is a crude marker for individual health status. Our clinicians use the constellation of data, including body composition, blood-based biomarkers and detailed discussions with you to determine the personalized approach that will help maximize your metabolic health and longevity.

Those who qualify and are deemed eligible candidates by our clinicians will be prescribed a semaglutide compounded medication. The main active ingredient for the compounded medications we are offering is semaglutide—the active ingredient in FDA-approved medications such as Novo Nordisk's Wegovy ® and Ozempic ®.

*Disclaimer: We are not affiliated with nor endorsed by Novo Nordisk or Eli Lily, who manufacture branded medications known as Ozempic, Wegovy, Mounjaro, and Zepbound. We currently do not offer branded prescription medications, and those seeking to be prescribed branded medications should seek alternate healthcare avenues.

Semaglutide is a glucagon-like peptide 1 receptor agonist used to improve metabolic health and support weight loss as an adjunct to lifestyle changes. This active ingredient in FDA-approved medications have become the leading drug in its class due to its proven safety and efficacy.

Possible side effects include: Nausea, diarrhea, vomiting, constipation, mild to moderate abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, belching, hypoglycemia, flatulence, gastroenteritis, loss of lean muscle mass and gastroesophageal reflux disease. Common injection site reactions are characterized by itching and burning at the site of administration with or without thickening of the skin (welting).

Program costs include an intake cost of $100-$150, depending on the studio location and biomarker lab testing. Those who qualify and are deemed eligible candidates for medication by our clinicians will then pay a monthly membership fee of $600-$675, depending on the medication that is prescribed. It is important to note your monthly membership includes medication, ongoing telemedicine visits with a Nurse Practitioner, personalized progress tracking, bi-annual biomarker labs and continuing guidance for your weight loss journey.

Yes, for those who qualify and are deemed eligible candidates by our clinicians, the semaglutide medication is included in the monthly cost of the program.

Drug compounding is the process of combining or mixing ingredients to create a medication tailored to an individual patient's needs. Compounded drugs are not FDA-approved, but the main active ingredient in our medications, semaglutide is the active ingredient in FDA-approved medications such as Ozempic. Restore’s supply chain team has done due diligence to ensure that our partnered pharmacies use the main active ingredients for our weight loss medications as those in popular FDA-approved medications and that our partnered pharmacies use the FDA-approved API to compound semaglutide.

It is important to understand that your physiology is unique. Everyone responds differently to medical therapies, and the same is true for semaglutide. Semaglutide has been shown to reduce weight for patients with overweight or obesity in randomized controlled trials. The STEP-1 trial tested the effect of high-dose semaglutide to produce weight loss in people with obesity who do not have diabetes. The results revealed an average 14.9% reduction in body weight from baseline during 68 weeks of treatment with semaglutide 2.4 mg plus a lifestyle intervention, compared with just a 2.4% reduction in the placebo plus lifestyle intervention group. It is important to note that real-world results from this therapy often differ from the results from controlled clinical trials.

Insurance is not required for the Weight Management Program, as the monthly scheduled telemedicine visits and medications are included in the monthly cost of the Program.

The decision to use a weight -loss medication is a personal decision that requires shared decision-making between you and your clinical provider. At Restore, our Weight Management Program is designed to improve metabolic health and support your longevity. While we understand that many people want to lose weight for a variety of different reasons, our clinicians focus on using our advanced therapies and in-studio offerings to advance your metabolic health, i.e., how your body manages and uses energy, which is critical to your long-term health and vitality.

Your eligibility will be based on a consultation with one of our expertly trained clinicians. If approved, we will determine the best way to implement and tailor our Weight Management Program to your needs.

Currently, our program is designed to guide clients down a personalized weight loss journey. It is not a traditional healthcare avenue for patients to seek treatment outside the established clinical guidelines of the Weight Management Program. If you are seeking care for something other than weight management, we advise you to seek an alternative healthcare provider.